Nutraceuticals Market Potential Still Piques J&J's Interest

Johnson & Johnson remains committed to building a presence in the nutraceuticals market despite the slow start of its Benecol franchise in the U.S., Chairman and CEO Ralph Larsen reaffirmed during an analysts' conference call on year-end financial results Jan. 25.